OSBPL9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.779900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.574100E-02
Normal-vs-Stage2
4.639800E-02
Normal-vs-Stage3
6.621000E-03
Normal-vs-Stage4
5.094800E-01
Stage1-vs-Stage2
4.633200E-01
Stage1-vs-Stage3
3.394800E-01
Stage1-vs-Stage4
7.080000E-02
Stage2-vs-Stage3
1.150010E-01
Stage2-vs-Stage4
1.199250E-01
Stage3-vs-Stage4
6.281300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.285500E-02
Normal-vs-AfricanAmerican
1.273750E-01
Normal-vs-Asian
1.236420E-01
Caucasian-vs-AfricanAmerican
9.304800E-01
Caucasian-vs-Asian
7.193800E-01
AfricanAmerican-vs-Asian
8.159200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.459900E-02
Normal-vs-Female
4.742400E-02
Male-vs-Female
1.192210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.004580E-01
Normal-vs-Age(41-60Yrs)
5.586200E-02
Normal-vs-Age(61-80Yrs)
3.598100E-02
Normal-vs-Age(81-100Yrs)
4.438500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.795420E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.269200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.934800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.620470E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.860000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.039400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.716300E-02
Normal-vs-Daily Drinker
1.513830E-02
Normal-vs-Weekly Drinker
5.387800E-02
Normal-vs-Occasional Drinker
8.047600E-02
Normal-vs-Social Drinker
9.784300E-02
Non Drinker-vs-Daily Drinker
1.642780E-01
Non Drinker-vs-Weekly Drinker
6.098200E-01
Non Drinker-vs-Occasional Drinker
4.614200E-01
Non Drinker-vs-Social Drinker
3.265600E-01
Daily Drinker-vs-Weekly Drinker
5.253600E-01
Daily Drinker-vs-Occasional Drinker
5.349900E-02
Daily Drinker-vs-Social Drinker
3.619700E-02
Weekly Drinker-vs-Occasional Drinker
2.817600E-01
Weekly Drinker-vs-Social Drinker
2.041600E-01
Occasional Drinker-vs-Social Drinker
7.814800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.007800E-01
Normal-vs-Grade 2
5.216400E-01
Normal-vs-Grade 3
5.097200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.263280E-03
Grade 1-vs-Grade 3
5.038500E-03
Grade 1-vs-Grade 4
3.007800E-01
Grade 2-vs-Grade 3
6.966800E-01
Grade 2-vs-Grade 4
5.216400E-01
Grade 3-vs-Grade 4
5.097200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.088300E-02
Normal-vs-NonDiabetic
2.765900E-02
Diabetic-vs-NonDiabetic
8.173800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.911500E-02
Normal-vs-NoPancreatitis
3.308300E-02
Pancreatitis-vs-NoPancreatitis
9.994600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.083500E-02
Normal-vs-N1
3.571800E-02
N0-vs-N1
5.653000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.144370E-01
Normal-vs-TP53-NonMutant
7.613500E-02
TP53-Mutant-vs-TP53-NonMutant
1.155570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
